Exercise Program. Ref: Priority Driven Collaborative Priority Driven Cancer Research Scheme Collaborative Walter & Eliza Hall (PDCCRS) 2016: Cancer Cancer Institute of Medical Transcriptional control of IL-17 $98,222.00 31/03/2017 24 Parkville 3052 Australia Research Research producing T cells in Scheme gastrointestinal cancers: ID1123388. Ref: CA-G1516/76 Priority Driven Collaborative Cancer Research Scheme (PDCCRS) 2016: Phase III Intergroup Study of Radiotherapy with Priority Driven Concomitant and Adjuvant Collaborative Prince of Wales Cancer Temozolomide versus The University of Cancer Hospital, University $221,534.04 04/04/2017 36 2006 Australia Radiotherapy with Adjuvant Sydney Research of Sydney PCV Chemotherapy in Scheme Patients with 1p/19q Anaplastic Glioma or Low Grade Glioma: the CODEL trial: ID1130584. Ref: CA-G1516/67 Priority Driven Collaborative Cancer Research Scheme Priority Driven (PDCCRS) 2016: Collaborative Lowy Cancer Reprogramming the Tumour Cancer Cancer Research Centre, Microenvironment with the $247,983.25 04/04/2017 36 Sydney 2052 Australia Research University of NSW use of Nanomedicines for the Scheme Treatment of Pancreatic Cancer: ID1126736. Ref: Priority Driven Collaborative Priority Driven Cancer Research Scheme Council of the Collaborative (PDCCRS) 2016: Dnmt3a loss Cancer Queensland Cancer contributes to disease $100,000.00 04/04/2017 24 Herston 4006 Australia Institute of Medical Research progression in Research Scheme myeloproliferative neoplasm: ID1124096. Ref: CA-G1516/77
Exercise Program. Ref: Cancer Australia Priority Driven Collaborative Cancer Research Scheme Walter & Eliza Hall Institute of Medical Research Priority Driven Collaborative Cancer Research Scheme (PDCCRS) 2016: Transcriptional control of IL-17 producing T cells in gastrointestinal cancers: ID1123388. Ref: CA-G1516/76 $98,222.00 31/03/2017 24 Parkville 3052 Cancer Australia Priority Driven Collaborative Cancer Research Scheme Prince of Wales Hospital, University of Sydney Priority Driven Collaborative Cancer Research Scheme (PDCCRS) 2016: Phase III Intergroup Study of Radiotherapy with Concomitant and Adjuvant Temozolomide versus Radiotherapy with Adjuvant PCV Chemotherapy in Patients with 1p/19q Anaplastic Glioma or Low Grade Glioma: the CODEL trial: ID1130584. Ref: CA-G1516/67 $221,534.04 04/04/2017 36 The University of Sydney 2006 Cancer Australia Priority Driven Collaborative Cancer Research Scheme Lowy Cancer Research Centre, University of NSW Priority Driven Collaborative Cancer Research Scheme (PDCCRS) 2016: Reprogramming the Tumour Microenvironment with the use of Nanomedicines for the Treatment of Pancreatic Cancer: ID1126736. Ref: $247,983.25 04/04/2017 36 Sydney 2052 Cancer Australia Priority Driven Collaborative Cancer Research Scheme Council of the Queensland Institute of Medical Research Priority Driven Collaborative Cancer Research Scheme (PDCCRS) 2016: Dnmt3a loss contributes to disease progression in myeloproliferative neoplasm: ID1124096. Ref: CA-G1516/77 $100,000.00 04/04/2017 24 Herston 4006
grants_reporting_20170922.docx